007310:KRXOTOKI Corporation Analysis
Data as of 2026-05-27 - not real-time
₩340,500.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Otoki Corp. is trading at KRW 340,500, barely above its recent support of KRW 336,500, while the 20‑day SMA (KRW 354,575) and 50‑day SMA (KRW 360,480) sit higher, underscoring a bearish price bias. Technical gauges reinforce this view: the 14‑day RSI at 38 signals the stock is edging toward oversold territory, yet the MACD line remains negative (‑5,612) with a bearish histogram, suggesting continued downward momentum. Fundamentally, the discounted cash‑flow model values the company at roughly KRW 176,800, less than half the current price, yielding an overvaluation signal and a downside potential of over 40%.
On the positive side, the stock offers a 2.63% dividend yield with a payout ratio around 43%, supported by solid operating cash flow and a low beta (~0.42), indicating limited market‑wide volatility. The consumer‑defensive food sector provides a stable backdrop, though modest revenue growth (3.7%) and thin margins limit upside catalysts.
On the positive side, the stock offers a 2.63% dividend yield with a payout ratio around 43%, supported by solid operating cash flow and a low beta (~0.42), indicating limited market‑wide volatility. The consumer‑defensive food sector provides a stable backdrop, though modest revenue growth (3.7%) and thin margins limit upside catalysts.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Bearish MACD and RSI approaching oversold
- Current price above DCF fair value
- Proximity to technical support with limited upside
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Attractive dividend yield with sustainable payout
- Defensive consumer‑staples sector cushioning volatility
- Low beta indicating limited market‑wide risk
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Stable cash flow generation supporting dividend
- Sector fundamentals remain resilient
- Valuation gap may persist without earnings acceleration
Key Metrics & Analysis
Financial Health
Revenue Growth3.70%
Profit Margin1.94%
P/E Ratio9.6
ROE3.37%
ROA3.03%
Debt/Equity38.49
Op. Cash Flow₩261.7B
Free Cash Flow₩53.9B
Technical Analysis
TrendBearish
RSI38.2
Support₩336,500.00
Resistance₩369,500.00
MA 20₩354,575.00
MA 50₩360,480.00
MA 200₩383,582.50
MACDBearish
VolumeStable
Fear & Greed Index91.04
Valuation
Fair Value₩176,794.13
Target Price₩520,000.00
Upside/Downside52.72%
GradeOvervalued
TypeValue
Dividend Yield2.63%
Risk Assessment
Beta0.42
Volatility24.86%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.